{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:37:55Z","timestamp":1789087075164,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.pntd.0013875","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000}}],"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC2506000"],"award-info":[{"award-number":["2023YFC2506000"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFC2301800"],"award-info":[{"award-number":["2021YFC2301800"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC81900572"],"award-info":[{"award-number":["NSFC81900572"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with high mortality. Neurological symptoms are increasingly recognized as critical predictors of poor outcomevs, but their mechanisms remain unclear. This study aims to explore relevant mechanisms and identify biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study utilized three distinct SFTS patient cohorts. First, 15 hospitalized patients from April 21 to August 2, 2024 were prospectively enrolled, with blood samples collected during hospitalization for RNA sequencing of peripheral blood mononuclear cells (PBMCs) to identify differentially expressed genes (DEGs). Second, we established a single-center retrospective cohort comprising 103 SFTS patients (admitted 2021\u20132024) to analyze clinical data pertaining to central nervous system (CNS) symptoms and patient outcomes. Third, to quantitatively assess serum matrix metalloproteinase-8 (\n                      <jats:italic>MMP8<\/jats:italic>\n                      ) levels, we analyzed a total of 151 serum samples obtained from patients across two independent centers using enzyme-linked immunosorbent assay (ELISA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      RNA sequencing analysis between the recovered group and deceased group revealed significant alterations in central nervous system (CNS)-related pathways. Clinical data from 103 SFTS patients showed the deceased group had significantly higher rates of neurological symptoms vs the recovered group over the full course: consciousness disorders (88.89% vs 23.53%, P\u2009&lt;\u20090.001) and convulsions (27.78% vs 3.53%, P\u2009=\u20090.003). Patients with these symptoms had both upregulated\n                      <jats:italic>MMP8<\/jats:italic>\n                      gene expression and elevated serum\n                      <jats:italic>MMP8<\/jats:italic>\n                      levels. Elevated serum\n                      <jats:italic>MMP8<\/jats:italic>\n                      strongly correlated with fatal outcomes (AUC\u2009=\u20090.821, 95% CI: 0.681-0.962; P\u2009=\u20090.008). Multivariate Cox analysis confirmed\n                      <jats:italic>MMP8<\/jats:italic>\n                      as an independent mortality predictor (HR\u2009=\u20091.060, 95% CI: 1.010-1.112). The\n                      <jats:italic>MMP8<\/jats:italic>\n                      -incorporated multivariable Cox model showed good discriminative ability in the external validation cohort (AUC\u2009=\u20090.843, 95% CI: 0.723-0.962).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Neurological symptoms during the early stages of SFTS are strongly associated with patient outcomes.\n                      <jats:italic>MMP8<\/jats:italic>\n                      may serve as a potential biomarker for SFTS prognosis. The integration of clinical neurological symptoms and\n                      <jats:italic>MMP8<\/jats:italic>\n                      measurement offers a novel framework for improving prognostic accuracy and guiding personalized management strategies in SFTS patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0013875","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T18:46:42Z","timestamp":1766774802000},"page":"e0013875","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neurological manifestations and MMP8 as a prognostic biomarker in severe fever with thrombocytopenia syndrome"],"prefix":"10.1371","volume":"19","author":[{"given":"Qi","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingtong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2892-5956","authenticated-orcid":true,"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"16","key":"pntd.0013875.ref001","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"X-J Yu","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"pntd.0013875.ref002","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1473-3099(18)30293-7","article-title":"Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study","volume":"18","author":"H Li","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"pntd.0013875.ref003","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3892\/ijmm.2022.5174","article-title":"Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review)","volume":"50","author":"T Yang","year":"2022","journal-title":"Int J Mol Med"},{"issue":"6","key":"pntd.0013875.ref004","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.4269\/ajtmh.16-0251","article-title":"Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome During an Outbreak in South Korea, 2013-2015","volume":"95","author":"S-W Park","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0013875.ref005","doi-asserted-by":"crossref","unstructured":"Tran X C, Yun Y, An L V, et al. Endemic severe fever with thrombocytopenia syndrome, vietnam - volume 25, number 5\u2014may 2019 - emerging infectious diseases journal - CDC. no date].","DOI":"10.3201\/eid2505.181463"},{"issue":"10","key":"pntd.0013875.ref006","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3201\/eid2110.141928","article-title":"Characteristics and Factors Associated with Death among Patients Hospitalized for Severe Fever with Thrombocytopenia Syndrome, South Korea, 2013","volume":"21","author":"J Shin","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"pntd.0013875.ref007","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/infdis\/jiv144","article-title":"Phylogenetic and Geographic Relationships of Severe Fever With Thrombocytopenia Syndrome Virus in China, South Korea, and Japan","volume":"212","author":"T Yoshikawa","year":"2015","journal-title":"J Infect Dis"},{"issue":"8","key":"pntd.0013875.ref008","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(14)70718-2","article-title":"Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis","volume":"14","author":"Q Liu","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"pntd.0013875.ref009","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3201\/eid2607.190611","article-title":"Serologic Evidence of Severe Fever with Thrombocytopenia Syndrome Virus and Related Viruses in Pakistan","volume":"26","author":"A Zohaib","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"pntd.0013875.ref010","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1080\/23744235.2024.2370965","article-title":"Serologic evidence of human exposure to the severe fever with thrombocytopenia syndrome virus and associated viruses in Kenya","volume":"56","author":"A Zohaib","year":"2024","journal-title":"Infect Dis (Lond)"},{"issue":"1","key":"pntd.0013875.ref011","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1038\/s41467-021-25804-z","article-title":"A longitudinal sampling study of transcriptomic and epigenetic profiles in patients with thrombocytopenia syndrome","volume":"12","author":"Y Wang","year":"2021","journal-title":"Nat Commun"},{"issue":"7","key":"pntd.0013875.ref012","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/infdis\/jis472","article-title":"Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients","volume":"206","author":"Z-T Gai","year":"2012","journal-title":"J Infect Dis"},{"issue":"2","key":"pntd.0013875.ref013","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cid\/cir776","article-title":"Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact","volume":"54","author":"Z Gai","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"11","key":"pntd.0013875.ref014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080802","article-title":"Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China","volume":"8","author":"B Deng","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"pntd.0013875.ref015","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cid\/cit530","article-title":"Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome","volume":"57","author":"W Liu","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pntd.0013875.ref016","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcv.2013.10.024","article-title":"Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China","volume":"59","author":"N Cui","year":"2014","journal-title":"J Clin Virol"},{"issue":"6","key":"pntd.0013875.ref017","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7883\/yoken.67.423","article-title":"Effects of ribavirin on severe fever with thrombocytopenia syndrome virus in vitro","volume":"67","author":"M Shimojima","year":"2014","journal-title":"Jpn J Infect Dis"},{"issue":"5","key":"pntd.0013875.ref018","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s40121-023-00808-y","article-title":"A Reservoir Computing with Boosted Topology Model to Predict Encephalitis and Mortality for Patients with Severe Fever with Thrombocytopenia Syndrome: A Retrospective Multicenter Study","volume":"12","author":"H Zheng","year":"2023","journal-title":"Infect Dis Ther"},{"issue":"6","key":"pntd.0013875.ref019","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1002\/jmv.26544","article-title":"Severe fever with thrombocytopenia syndrome in Hefei: Clinical features, risk factors, and ribavirin therapeutic efficacy","volume":"93","author":"Y Zhang","year":"2021","journal-title":"J Med Virol"},{"issue":"1","key":"pntd.0013875.ref020","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1186\/s12879-021-06627-1","article-title":"Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis\/encephalopathy: a retrospective study","volume":"21","author":"Y Xu","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pntd.0013875.ref021","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jinf.2014.08.001","article-title":"Severe fever with thrombocytopenia syndrome bunyavirus-related human encephalitis","volume":"70","author":"N Cui","year":"2015","journal-title":"J Infect"},{"issue":"9","key":"pntd.0013875.ref022","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29921","article-title":"A nomogram and heat map based on LASSO-Cox regression for predicting the risk of early-stage severe fever with thrombocytopenia syndrome patients developing into critical illness at 7-day and 14-day","volume":"96","author":"H Tong","year":"2024","journal-title":"J Med Virol"},{"issue":"1","key":"pntd.0013875.ref023","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7883\/yoken.JJID.2024.015","article-title":"Prediction of Prognosis in Patients with Severe Fever with Thrombocytopenia Syndrome","volume":"78","author":"Y Zhang","year":"2025","journal-title":"Jpn J Infect Dis"},{"issue":"1","key":"pntd.0013875.ref024","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12985-017-0682-z","article-title":"Establishment of national reference for bunyavirus nucleic acid detection kits for diagnosis of SFTS virus","volume":"14","author":"X Lu","year":"2017","journal-title":"Virol J"},{"issue":"11","key":"pntd.0013875.ref025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007829","article-title":"A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage-A multicenter study in China","volume":"13","author":"L Wang","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0013875.ref026","article-title":"A new model for predicting the outcome and effectiveness of drug therapy in patients with severe fever with thrombocytopenia syndrome: A multicenter Chinese study","volume":"17","author":"G Xia","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0013875.ref027","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1080\/21505594.2021.1899674","article-title":"Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage","volume":"12","author":"U Ashraf","year":"2021","journal-title":"Virulence"},{"issue":"4","key":"pntd.0013875.ref028","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3390\/ijms26041503","article-title":"The Factors Associated with the Blood-Brain Barrier Dysfunction in Tick-Borne Encephalitis","volume":"26","author":"S Grygorczuk","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"10","key":"pntd.0013875.ref029","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1128\/JVI.00143-15","article-title":"Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection","volume":"89","author":"F Li","year":"2015","journal-title":"J Virol"},{"issue":"2","key":"pntd.0013875.ref030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/CCM.0b013e318232e404","article-title":"A novel role for matrix metalloproteinase-8 in sepsis","volume":"40","author":"PD Solan","year":"2012","journal-title":"Crit Care Med"},{"issue":"1","key":"pntd.0013875.ref031","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1038\/s41467-025-59281-5","article-title":"A shared inflammatory signature across severe malaria syndromes manifested by transcriptomic, proteomic and metabolomic analyses","volume":"16","author":"RS Sobota","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"pntd.0013875.ref032","doi-asserted-by":"crossref","first-page":"2498572","DOI":"10.1080\/22221751.2025.2498572","article-title":"A machine learning model for mortality prediction in patients with severe fever with thrombocytopenia syndrome: a prospective, multicenter cohort study","volume":"14","author":"Y Liu","year":"2025","journal-title":"Emerg Microbes Infect"},{"issue":"8","key":"pntd.0013875.ref033","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.cmi.2025.02.004","article-title":"Development and validation of a novel mortality risk stratification simplified scoring scale for severe fever with thrombocytopenia syndrome","volume":"31","author":"T Chen","year":"2025","journal-title":"Clin Microbiol Infect"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0013875","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T19:06:57Z","timestamp":1767380817000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013875"}},"subtitle":[],"editor":[{"given":"Shu","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013875","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}